Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Operations (Unaudited)

v3.22.2.2
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Revenue:        
Total revenue $ 7,291 $ 328,459 $ 59,874 $ 3,098,661
Revenue from Contract with Customer, Product and Service [Extensible List] us-gaap:GrantMember us-gaap:GrantMember us-gaap:GrantMember us-gaap:GrantMember
Costs and expenses:        
Research and development $ 2,981,653 $ 3,154,553 $ 8,980,827 $ 7,968,846
Selling, general and administrative 1,538,737 1,644,946 4,872,681 4,854,494
Total costs and expenses 4,520,390 4,799,499 13,853,508 12,823,340
Loss from operations (4,513,099) (4,471,040) (13,793,634) (9,724,679)
Interest income 18,536 0 18,536 0
Interest expense 0 (157) (5) (19,765)
Net loss (4,494,563) (4,471,197) (13,775,103) (9,744,444)
Unrealized gains on marketable securities 26,828 0 26,828 0
Comprehensive loss $ (4,467,735) $ (4,471,197) $ (13,748,275) $ (9,744,444)
Net loss per share - basic $ (0.18) $ (0.18) $ (0.55) $ (0.61)
Net loss per share - diluted $ (0.18) $ (0.18) $ (0.55) $ (0.61)
Weighted average number of common share basic 25,227,051 25,143,559 25,219,931 15,868,421
Weighted Average Number of Shares Outstanding, Diluted 25,227,051 25,143,559 25,219,931 15,868,421